Skip to content
Contact
0
IDKmonitor Adalimumab free anti-drug antibody assay
Back To Our Shop

Adalimumab Free Anti-drug Antibody ELISA (IDKmonitor®)

Adalimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response.

Categories:, ,
Download Brochure Technical Support Request a Quote

Key Advantages

Supports the investigation of primary non-response and loss of response to adalimumab

Highly sensitive assay that only detects free anti-adalimumab antibodies

May help predict long term outcome of disease

Applicable to both gastroenterology and rheumatology

Automatable on ELISA automates (e.g. Dynex DS2)

Unboxing of Peptest

Interested in this product? Get in touch

Our team of experts are on hand to answer any questions you may have about this product, or any of our other offerings.
  • Product code: Product code: K9652 (96 wells)

Determination of free anti-adalimumab antibodies

Adalimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Adalimumab Free Anti-drug ELISA kit is a microplate-based quantitative sandwich ELISA for the determination of free anti-adalimumab antibodies in plasma or serum samples. Detecting high levels of free anti-adalimumab antibodies in patients when the drug level is low (undetectable or sub-therapeutic) may indicate poorer long-term outcomes and suggest the need to switch treatment.

Please contact us for your nearest test reference laboratory.

  • ELISA

  • 45 tests

  • Storage: 2-8 °C

  • Blood sample